Clinical trial
Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in…
NCT00480324 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00480324 |
|---|---|
| Title | Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants |
| Official title | Efficacy, Safety, Reactogenicity and Immunogenicity Study of the Lyophilised Formulation of Rotarix Vaccine in Healthy Japanese Infants |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections, Rotavirus, Rotavirus Vaccines |
| Intervention type | Biological |
| Interventions | Rotarix, Placebo |
| Enrollment | 765 |
| Start date | Jun 19, 2007 |
| Primary completion | Mar 31, 2009 |
| Completion | Nov 21, 2009 |
| First posted | May 30, 2007 |
| Last update posted | Jan 2, 2020 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: